0.46 USD
↗ 0.03 (6.70%)AT CLOSE (03:59 PM EDT)
BeyondSpring Inc. Ordinary Shares
BYSINASDAQ • USD
0.46
↘ 0.00 (0.22%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
0.46
↘ 0.00 (0.22%)
Market: CLOSED
Shares of BeyondSpring Inc. Ordinary Shares (BYSI) are trading at $0.45. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 26, 2026.
Open?$0.43
High?$0.48
Low?$0.43
Prev. Close?$0.43
Volume?52.0K
Avg. Volume?405.4K
VWAP?$0.46
Rel. Volume?0.13x
Bid / Ask
Bid?$0.42 × 1.3K
Ask?$0.47 × 800
Spread?$0.05
Midpoint?$0.45
Valuation & Ratios
Market Cap?18.9M
Shares Out?41.1M
Float?31.3M
Float %?76.2%
P/E Ratio?N/A
P/B Ratio?-0.53
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
Employees
44
Market Cap
17.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2017-03-09
Address
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR
FLORHAM PARK, NJ 07932
Phone: 646-528-4184
FLORHAM PARK, NJ 07932
Phone: 646-528-4184
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?-40.79Distress
Confidence?54%Low
Short InterestVery High
Short % of Float?7.51%Elevated
Short Interest?2.4M
Days to Cover?35.8
Free Float31.3M
Avg Daily Volume65.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.66Adequate
Quick Ratio?1.66Adequate
Cash Ratio?0.45Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.53CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?18.8%STRONG▾
Peers50
S&P63
ROA?-45.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-16746000
Enterprise Value?$16.2M
Fundamentals ratios updated end of day